← Open Payments lookup

MICHAEL LEVINSON: Open Payments

NPI 1306876883 · BURLINGAME, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,866 in 123 payments from 12 companies in 2025. Trend: 2023 $11,984 · 2024 $3,529 · 2025 $3,866

Food & beverage: $3,866
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$704
E.R. Squibb & Sons, L.L.C.14$478
Vanda Pharmaceuticals Inc.16$424
Axsome Therapeutics, Inc.11$376
Lundbeck LLC12$363
Teva Pharmaceuticals USA, Inc.3$360
Neurocrine BioSciences, Inc.12$336
Alkermes, Inc.12$262
Otsuka America Pharmaceutical, Inc.6$237
Takeda Pharmaceuticals U.S.A., Inc.5$155

Products named: CAPLYTA, REXULTI, COBENFY, FANAPT, Auvelity, INGREZZA, ARISTADA, UZEDY.

Industry payments across CA — which companies pay providers there.